ArticleOncotarget2018

Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene system.

Ji Min Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.